Thursday, January 19, 2017

Adamis Pharmaceuticals Announces FDA Acceptance of Resubmission of Its Epinephrine Pre-Filled Syringe NDA

More EpiPen Rivals coming. Adamis Announces FDA Acceptance of Resubmission of Its Epinephrine Pre-Filled Syringe NDA #breakingnews #breaking #news #trending #new #happening #now   http://ift.tt/2k7wr1R

No comments:

Post a Comment